|
Atomistry » Fluorine » PDB 4q0e-4qrc » 4qpf | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 4q0e-4qrc » 4qpf » |
Fluorine in PDB 4qpf: New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone ResorptionEnzymatic activity of New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption
All present enzymatic activity of New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption:
2.5.1.1; 2.5.1.10; Protein crystallography data
The structure of New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption, PDB code: 4qpf
was solved by
F.H.Ebetino,
M.Lundy,
A.A.Kwaasi,
J.E.Dunford,
Z.Duan,
J.Triffitt,
A.Mazur,
G.Jeans,
B.L.Barnett,
R.G.G.Russell,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 4qpf:
The structure of New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption
(pdb code 4qpf). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption, PDB code: 4qpf: Fluorine binding site 1 out of 1 in 4qpfGo back to Fluorine Binding Sites List in 4qpf
Fluorine binding site 1 out
of 1 in the New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption
Mono view Stereo pair view
Reference:
F.H.Ebetino,
M.Lundy,
A.A.Kwaasi,
J.E.Dunford,
Z.Duan,
J.Triffitt,
A.Mazur,
G.Jeans,
B.L.Barnett,
R.G.G.Russell.
New Lower Bone Affinity Bisphosphonate Drug Design For Effective Use in Diseases Characterized By Abnormal Bone Resorption To Be Published.
Page generated: Sun Dec 13 12:11:42 2020
|
Last articlesZn in 8WB0Zn in 8WAX Zn in 8WAU Zn in 8WAZ Zn in 8WAY Zn in 8WAV Zn in 8WAW Zn in 8WAT Zn in 8W7M Zn in 8WD3 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |